Page last updated: 2024-08-18

pyrazolanthrone and Peritoneal Diseases

pyrazolanthrone has been researched along with Peritoneal Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, W; Dong, X; Liu, Q; Mao, H; Nie, J; Yang, Q; Yu, X1

Other Studies

1 other study(ies) available for pyrazolanthrone and Peritoneal Diseases

ArticleYear
Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2008, Volume: 28 Suppl 3

    Topics: Actins; Animals; Anthracenes; Cadherins; Collagen Type I; Epithelial Cells; Fibrosis; Gene Expression Regulation; JNK Mitogen-Activated Protein Kinases; Male; Peritoneal Diseases; Peritoneum; Phosphorylation; Rats; Rats, Sprague-Dawley; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1

2008